Avalo Therapeutics, Inc. (AVTX) Form 10-Q Quarterly Reports
Avalo Therapeutics, Inc. (AVTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AVTX
CIK: 1534120
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJeremiah Ward
Audit LocationJericho, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-09-30 | 4 Filing | 0001707797-26-000017 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | 4 Filing | 0001677036-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | 4 Filing | 0002063957-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | 4 Filing | 0001810417-26-000023 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-10 | 4 Filing | 0001810417-26-000021 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-28 | 4 Filing | 0001918845-26-000031 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 Filing | 0001810417-26-000019 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 Filing | 0001918845-26-000029 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001950047-26-008317 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001950047-26-008276 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001950047-26-008273 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001950047-26-008220 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097285 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001727492-26-000021 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000918 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000921895-26-002164 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001897612-26-000606 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000902664-26-003460 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003475 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001011438-26-000509 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-11 | 4 Filing | 0002047607-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | 4 Filing | 0001918845-26-000026 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001950047-26-007948 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001950047-26-007908 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-07 | — | SCHEDULE 13G/A Filing | 0000315066-26-002249 | View SEC Doc Filr Page |